XML 87 R76.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidating Financial Information - Statement of Cash Flows (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash Flow from Operating Activities:    
Net cash provided by operating activities $ 220,223 $ 57,905
Cash Flow from Investing Activities:    
Insurance proceeds - damaged property 5,998 86
Acquisition of CEC, net of cash acquired 0 (353,555)
Proceeds from sale of property and equipment 2,061 856
Proceeds from sale of assets held for sale 3,797 0
Change in restricted investments (2,413) (3,810)
Capital expenditures (161,490) (104,130)
Net cash used in investing activities (152,047) (460,553)
Cash Flow from Financing Activities:    
Proceeds from long-term debt 372,000 1,324,865
Payments on long-term debt (186,033) (1,093,088)
Payments on non-recourse debt (9,636) (68,887)
Proceeds from non-recourse debt 0 123,785
Taxes paid related to net share settlements of equity awards (4,452) (4,122)
Payment for repurchases of common stock (70,446) 0
Proceeds from issuance of common stock in connection with ESPP 404 382
Proceeds from issuance of common stock in connection with public offering 0 275,867
Debt issuance costs (990) (9,470)
Proceeds from the exercise of stock options 1,781 6,786
Cash dividends paid (172,256) (169,152)
Net cash (used in) provided by financing activities (69,628) 386,966
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash and Cash Equivalents (5,392) 863
Net Decrease in Cash, Cash Equivalents and Restricted Cash and Cash Equivalents (6,844) (14,819)
Cash, Cash Equivalents and Restricted Cash and Cash Equivalents, beginning of period 133,545 90,357
Cash, Cash Equivalents and Restricted Cash and Cash Equivalents, end of period 126,701 75,538
The GEO Group, Inc.    
Cash Flow from Operating Activities:    
Net cash provided by operating activities 112,599 15,303
Cash Flow from Investing Activities:    
Insurance proceeds - damaged property 0 86
Acquisition of CEC, net of cash acquired   (353,555)
Proceeds from sale of property and equipment 0 845
Proceeds from sale of assets held for sale 0  
Change in restricted investments 0 0
Capital expenditures (95,461) (34,679)
Net cash used in investing activities (95,461) (387,303)
Cash Flow from Financing Activities:    
Proceeds from long-term debt 372,000 1,324,865
Payments on long-term debt (183,000) (1,093,088)
Payments on non-recourse debt 0 0
Proceeds from non-recourse debt   0
Taxes paid related to net share settlements of equity awards (4,452) (4,122)
Payment for repurchases of common stock (70,446)  
Proceeds from issuance of common stock in connection with ESPP 404 0
Proceeds from issuance of common stock in connection with public offering   275,867
Debt issuance costs (990) (8,701)
Proceeds from the exercise of stock options 1,781 6,786
Cash dividends paid (172,256) (169,152)
Net cash (used in) provided by financing activities (56,959) 332,455
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash and Cash Equivalents 0 0
Net Decrease in Cash, Cash Equivalents and Restricted Cash and Cash Equivalents (39,821) (39,545)
Cash, Cash Equivalents and Restricted Cash and Cash Equivalents, beginning of period 54,666 45,736
Cash, Cash Equivalents and Restricted Cash and Cash Equivalents, end of period 14,845 6,191
Combined Subsidiary Guarantors    
Cash Flow from Operating Activities:    
Net cash provided by operating activities 70,040 79,088
Cash Flow from Investing Activities:    
Insurance proceeds - damaged property 5,998 0
Acquisition of CEC, net of cash acquired   0
Proceeds from sale of property and equipment 0 0
Proceeds from sale of assets held for sale 3,797  
Change in restricted investments (2,413) (3,810)
Capital expenditures (64,015) (61,432)
Net cash used in investing activities (56,633) (65,242)
Cash Flow from Financing Activities:    
Proceeds from long-term debt 0 0
Payments on long-term debt 0 0
Payments on non-recourse debt 0 0
Proceeds from non-recourse debt   0
Taxes paid related to net share settlements of equity awards 0 0
Payment for repurchases of common stock 0  
Proceeds from issuance of common stock in connection with ESPP 0 0
Proceeds from issuance of common stock in connection with public offering   0
Debt issuance costs 0 0
Proceeds from the exercise of stock options 0 0
Cash dividends paid 0 0
Net cash (used in) provided by financing activities 0 0
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash and Cash Equivalents 0 0
Net Decrease in Cash, Cash Equivalents and Restricted Cash and Cash Equivalents 13,407 13,846
Cash, Cash Equivalents and Restricted Cash and Cash Equivalents, beginning of period 4,952 4,922
Cash, Cash Equivalents and Restricted Cash and Cash Equivalents, end of period 18,359 18,768
Combined Non-Guarantor Subsidiaries    
Cash Flow from Operating Activities:    
Net cash provided by operating activities 37,584 (36,486)
Cash Flow from Investing Activities:    
Insurance proceeds - damaged property 0 0
Acquisition of CEC, net of cash acquired   0
Proceeds from sale of property and equipment 2,061 11
Proceeds from sale of assets held for sale 0  
Change in restricted investments 0 0
Capital expenditures (2,014) (8,019)
Net cash used in investing activities 47 (8,008)
Cash Flow from Financing Activities:    
Proceeds from long-term debt 0 0
Payments on long-term debt (3,033) 0
Payments on non-recourse debt (9,636) (68,887)
Proceeds from non-recourse debt   123,785
Taxes paid related to net share settlements of equity awards 0 0
Payment for repurchases of common stock 0  
Proceeds from issuance of common stock in connection with ESPP 0 382
Proceeds from issuance of common stock in connection with public offering   0
Debt issuance costs 0 (769)
Proceeds from the exercise of stock options 0 0
Cash dividends paid 0 0
Net cash (used in) provided by financing activities (12,669) 54,511
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash and Cash Equivalents (5,392) 863
Net Decrease in Cash, Cash Equivalents and Restricted Cash and Cash Equivalents 19,570 10,880
Cash, Cash Equivalents and Restricted Cash and Cash Equivalents, beginning of period 73,927 39,699
Cash, Cash Equivalents and Restricted Cash and Cash Equivalents, end of period $ 93,497 $ 50,579